The other study I am most involved in is a study examining the treatment of insomnia in cancer survivors. The study compares the efficacy of cognitive behavioral therapy for insomnia (CBT-I) treatment with or without the use of a drug that is intended to reduce daytime fatigue. CBT-I is supposed to help those who suffer from insomnia manage their sleep habits at night in order to increase their sleep time and their sleep efficiency (which is a measure of time asleep vs. time spent in bed). The drug should help with insomnia by reducing daytime fatigue and allowing the person to actually be tired enough at night to fall asleep. So together these treatments should be better than either one alone. The study is double-blind (of course), with those participants not receiving the medication receiving a placebo instead. My role is mainly in recruitment of participants from the cancer clinic at Penn, as well as consenting/screening participants who seem eligible.
The other two studies I am less involved in, but I will detail in a later post.
No comments:
Post a Comment